Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 2/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4848165 | 0.98 | ALDH1A1 (0.56) | ALDH1A1TSHRTHRBDGKAHSD17B10 | |
| SCHEMBL8195672 | 0.84 | DGKA (0.42) | ALDH1A1TSHRTHRBDGKAHSD17B10 | |
| SCHEMBL4856120 | 0.83 | ALDH1A1 (0.54) | ALDH1A1TSHRTHRBDGKAHSD17B10 | |
| SCHEMBL1799780 | 0.83 | DGKA (0.39) | ALDH1A1TSHRTHRBDGKAHSD17B10 | |
| SCHEMBL106760 | 0.81 | ALDH1A1 (0.62) | ALDH1A1TSHRTHRBDGKAHSD17B10 | |
| SCHEMBL9598368 | 0.81 | ALDH1A1 (0.62) | ALDH1A1TSHRTHRBDGKAHSD17B10 | |
| SCHEMBL1301905 | 0.81 | ALDH1A1 (0.62) | ALDH1A1TSHRTHRBDGKAHSD17B10 | |
| SCHEMBL8195957 | 0.81 | — | — | |
| SCHEMBL4849689 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBDGKAHSD17B10 | |
| SCHEMBL8894704 | 0.81 | DGKA (0.48) | ALDH1A1TSHRTHRBDGKAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0684287-A1 | Water insoluble red monoazo dyes, their preparation and the use thereof | HOECHST MITSUBISHI KASEI CO., LTD. (JP) | 1995-11-29 | — | — | EP | claimed |
| US-5283326-A | Coupling azo and cyanine dyes; colorfastness, heat resistance | SANDOZ AG (CH) | 1994-02-01 | — | — | US | claimed |
| US-4960873-A | 3-pyridylisothiazoleazo compounds useful as disperse dyes | BASF AKTIENGESELLSCHAFT (DE) | 1990-10-02 | — | — | US | claimed |
| US-4837269-A | FIBER-REACTIVE DISAZO DYES | BASF AKTIENGESELLSCHAFT (DE) | 1989-06-06 | — | — | US | claimed |
| US-4751288-A | COLORFASTNESS | BASF AKTIENGESELLSCHAFT (DE) | 1988-06-14 | — | — | US | claimed |
| US-4619992-A | IMPROVED COLORFASTNESS | BASF AKTIENGESELLSCHAFT (DE) | 1986-10-28 | — | — | US | claimed |
| US-4496480-A | Isothiazolazo dyes having coupling components which are free from unsaturated aliphatic radicals | BASF AKTIENGESELLSCHAFT (DE) | 1985-01-29 | — | — | US | claimed |
| US-20190171099-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2019-06-06 | — | — | US | disclosed |
| US-10241399-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | BASF SE (DE) | 2019-03-26 | — | — | US | disclosed |
| EP-2668156-B1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2018-10-31 | — | — | EP | disclosed |
| US-9310677-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | BASF (DE) | 2016-04-12 | — | — | US | disclosed |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2016-03-03 | — | — | US | disclosed |
| EP-2668156-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2013-12-04 | — | — | EP | disclosed |
| EP-0156216-A1 | Isothiazole azo dyestuffs | BASF Aktiengesellschaft (DE) | 1985-10-02 | — | — | EP | disclosed |
| EP-0087677-B1 | ISOTHIAZOLAZO DYESTUFFS | BASF Aktiengesellschaft (DE) | 1985-07-17 | — | — | EP | disclosed |
| US-4496480-A | Isothiazolazo dyes having coupling components which are free from unsaturated aliphatic radicals | BASF AKTIENGESELLSCHAFT (DE) | 1985-01-29 | — | — | US | disclosed |
| EP-0131757-A1 | Disazo dyestuffs of the isothiazole series | BASF Aktiengesellschaft (DE) | 1985-01-23 | — | — | EP | disclosed |
| EP-0087677-A1 | Isothiazolazo dyestuffs | BASF Aktiengesellschaft (DE) | 1983-09-07 | — | — | EP | disclosed |
| US-4252604-A | OPTICAL BRIGHTENERS | SANDOZ LTD. (CH) | 1981-02-24 | — | — | US | disclosed |
| US-3935183-A | WATER INSOLUBLE DYE | IMPERIAL CHEMICAL INDUSTRIES LIMITED (EN) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10241399-B2 | Polymerizable composition comprising an oxime sulfonate as thermal curing agent | SULT1E1, COX6B1, SULT1A1 | ALDH1A1 776/4885TSHR 3974/4885THRB 1036/4885 |
| US-20190171099-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | SULT1E1, COX6B1, SULT1A1 | ALDH1A1 776/4885TSHR 3974/4885THRB 1036/4885 |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | SULT1E1, COX6B1, SULT1A1 | ALDH1A1 776/4885TSHR 3974/4885THRB 1036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.